Skip to main content
logo
Invicta Diagnostic Limited (NSE:INVICTA)
India flag India · Delayed Price · Currency is INR
74.35
+1.35 (1.85%)
At close: Jan 19, 2026

Invicta Diagnostic Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Revenue
300.95158.3168.4329.03-
Other Revenue
0.860.68---
Revenue
301.81158.9868.4329.03-
Revenue Growth (YoY)
89.84%132.33%135.74%--
Cost of Revenue
23.6314.679.567.93-
Gross Profit
278.18144.3258.8721.1-
Selling, General & Admin
74.935.1518.672.8-
Other Operating Expenses
110.4437.622315.550.03
Operating Expenses
210.2492.160.6849.510.03
Operating Income
67.9452.22-1.81-28.41-0.03
Interest Expense
-1.61-0.59---
Interest & Investment Income
--0.112.14-
Other Non Operating Income (Expenses)
-0.7-0.42-0.03-
EBT Excluding Unusual Items
65.6451.21-1.7-26.24-0.03
Gain (Loss) on Sale of Investments
---0--
Pretax Income
65.6451.21-1.71-26.24-0.03
Income Tax Expense
16.3413.16---
Earnings From Continuing Operations
49.338.05-1.71-26.24-0.03
Minority Interest in Earnings
-0.38-0.44---
Net Income
48.9237.61-1.71-26.24-0.03
Net Income to Common
48.9237.61-1.71-26.24-0.03
Net Income Growth
30.04%----
Shares Outstanding (Basic)
88---
Shares Outstanding (Diluted)
88---
EPS (Basic)
5.814.47---
EPS (Diluted)
5.814.47---
EPS Growth
30.04%----
Free Cash Flow
60.03-21.16---
Free Cash Flow Per Share
7.13-2.51---
Gross Margin
92.17%90.77%86.03%72.68%-
Operating Margin
22.51%32.84%-2.65%-97.88%-
Profit Margin
16.21%23.66%-2.50%-90.40%-
Free Cash Flow Margin
19.89%-13.31%---
EBITDA
92.8171.4317.212.75-
EBITDA Margin
30.75%44.93%25.15%9.47%-
D&A For EBITDA
24.8719.2119.0231.16-
EBIT
67.9452.22-1.81-28.41-0.03
EBIT Margin
22.51%32.84%-2.65%-97.88%-
Effective Tax Rate
24.90%25.69%---
Revenue as Reported
301.81158.9868.5431.2-
Advertising Expenses
10.845.054.42--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.